Delivery Order SPE2DB20D3111-SPE2DB25FA8RJ
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $1,518.00 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division for the supply of 4,565,497,445 units of Febuxostat 40 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,558,119,086 units of Febuxostat 40 mg tablets. The $2,347.52 firm fixed-price contract has an ultimate completion date of August 17, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a wide range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the delivery of febuxostat 40mg tablets. The contract is a delivery order with a firm fixed price of $1,103.44 and an ultimate completion date of August 13, 2024. This order is not designated as a set-aside. Amerisourcebergen, through its Corporate Office Division, has been awarded numerous federal contracts and...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide febuxostat 40 mg tablets. The $1,000.34 award has a completion date of January 31, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor to the DLA, providing a range of pharmaceutical products and medical supplies to support military treatment programs and facilities. This...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $792.74 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to supply 4562280546 FEBUXOSTAT 40 MG TABLET 30S. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The delivery order period of performance is September 22, 2023 through September 25, 2023. No subcontractors or set aside designations were indicated. DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,280.57 fixed-price contract is for the supply of febuxostat 40 mg tablets, a medication used to treat gout. The contract has an ultimate completion date of July 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a range of...
- This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,277.66, is for the delivery of 4562280454 ! FEBUXOSTAT 40 MG TABLET 30S. It is a firm fixed-price delivery order with a completion date of September 25, 2023. The contract is not associated with a set-aside designation. Amerisourcebergen Drug Corp is a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,639.36, is for the delivery of 30-count bottles of the medication febuxostat 40 mg tablets. The order has a completion date of May 21, 2025. Amerisourcebergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,672.36 contract is for the delivery of 30-count bottles of the medication febuxostat 40 mg tablets to support military treatment facilities and other federal healthcare programs. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,563,649,540 units of Febuxostat 40 mg tablets. The Firm Fixed Price delivery order, valued at $1,222.02, has a ceiling of $1,222.02 and a period of performance through February 14, 2024. The contract does not have a set-aside designation, indicating open competition. This award is likely part of a larger Indefinite Delivery Contract (IDC)...
- SPE2DB20D3111Indefinite Delivery Contract
- SPE2DB20D3111-SPE2DB25FA8RJDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,273.53 on July 28, 2025, for the supply of Febuxostat 80 mg tablets (30-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of July 29, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company holds an extensive portfolio of federal contract awards with the Defense Logistics Agency covering a broad spectrum of pharmaceutical products and medical supplies, ranging from generic medications to specialized healthcare commodities. All reviewed contract awards demonstrate AmerisourceBergen's capability to compete successfully in open competition, with delivery orders utilizing firm fixed pricing across transaction values. The DLA is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen to continue serving federal healthcare customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 7/28/25 |